Association of dynamic susceptibility contrast- and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas: A retrospective study. Issue 1 (February 2023)

• Record Type: Journal Article
• Authors: Ahn, Sung Hee; Ahn, Sung Soo; Park, Yae Won; Park, Chae Jung; Lee, Seung-Koo
• Is Part Of: Neuroradiology journal. Volume 36:Issue 1(2023)
• Page Start: 49
• Page End: 58
• Publication Date: 2023-02
• Subjects: glioma -- magnetic resonance imaging -- perfusion -- molecular marker -- permeability; Nervous system -- Radiography -- Periodicals; Neuroradiography -- Periodicals; Electronic journals; 616.804757
• DOI: 10.1177/19714009221098369
• Languages: English
• ISSNs: 1971-4009

Abstract

Purpose: Molecular marker status is clinically relevant for treatment planning and predicting the prognosis of gliomas. This study aimed to assess whether quantitative imaging parameters from dynamic susceptibility contrast- (DSC-) and dynamic contrast-enhanced (DCE)-magnetic resonance imaging (MRI) can predict the molecular marker status of lower-grade gliomas (LGGs). Materials and methods: Overall, 132 patients with LGGs who underwent DSC- and DCE-MRI were retrospectively enrolled. Statuses of relevant molecular markers including isocitrate dehydrogenase isoenzyme (IDH), 1p19q codeletion, epidermal growth factor receptor (EGFR), O6-methylguanine-DNA methyltransferase (MGMT), and telomerase reverse transcriptase (TERT) were collected. For each molecular marker, age, tumor diameter and location, and DSC- and DCE-MRI parameters, including the normalized cerebral blood volume (nCBV), volume transfer constant (Ktrans), rate transfer coefficient (Kep), extravascular extracellular volume fraction (Ve), and plasma volume fraction (Vp), were compared. Multivariable logistic regression analyses were performed. Results: The nCBV was significantly lower in LGGs with IDH mutation ( p = .001) and TERT mutation ( p = .027) than those without these mutations. Ktrans ( p = .034), Ve ( p = .023), and Vp ( p = .044) values were significantly lower in MGMT methylated LGGs than in MGMT unmethylated LGGs. Perfusion parameters were not significantly associated with EGFR amplification and 1p19q codeletion. Young age ( p < .001) and small diameter ( p = .001) were significantly associated with IDH mutation. The nCBV was independently associated with IDH status (AUC, 0.817; 95% CI: 0.739–0.894). Conclusions: DSC- and DCE-MRI parameters demonstrated correlations with molecular markers of LGGs. Especially, the nCBV can be helpful in predicting the IDH mutation status.